NCCN Guidelines® Insights: Kidney cancer, version 2.2024 Guidelines

  


Authors: Motzer, R. J.; Jonasch, E.; Agarwal, N.; Alva, A.; Bagshaw, H.; Baine, M.; Beckermann, K.; Carlo, M. I.; Choueiri, T. K.; Costello, B. A.; Derweesh, I. H.; Desai, A.; Ged, Y.; George, S.; Gore, J. L.; Gunn, A.; Haas, N.; Johnson, M.; Kapur, P.; King, J.; Kyriakopoulos, C.; Lam, E. T.; Lara, P. N.; Lau, C.; Lewis, B.; Madoff, D. C.; Manley, B.; Michaelson, M. D.; Mortazavi, A.; Ponsky, L.; Ramalingam, S.; Shuch, B.; Smith, Z. L.; Sosman, J.; Sweis, R.; Zibelman, M.; Schonfeld, R.; Stein, M. E.; Gurski, L. A.
Title: NCCN Guidelines® Insights: Kidney cancer, version 2.2024
Abstract: The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients with renal cell carcinoma (RCC). These NCCN Guidelines Insights focus on the systemic therapy options for patients with advanced RCC and summarize the new clinical data evaluated by the NCCN panel for the recommended therapies in Version 2.2024 of the NCCN Guidelines for Kidney Cancer.
Keywords: renal cell carcinoma; kidney neoplasms; kidney tumor; carcinoma, renal cell; humans; human
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 22
Issue: 1
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2024-02-01
Start Page: 4
End Page: 16
Language: English
DOI: 10.6004/jnccn.2024.0008
PUBMED: 38394781
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85185860641&doi=10.6004%2fjnccn.2024.0008&partnerID=40&md5=1766d92ed892db1b1d4747463c5b8877
Notes: Article -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer
  2. Maria Isabel Carlo
    162 Carlo
Related MSK Work